Antonio Giordani

1.2k total citations
37 papers, 900 citations indexed

About

Antonio Giordani is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Antonio Giordani has authored 37 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Pharmacology. Recurrent topics in Antonio Giordani's work include Inflammatory mediators and NSAID effects (12 papers), Chemical Synthesis and Analysis (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Antonio Giordani is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Chemical Synthesis and Analysis (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Antonio Giordani collaborates with scholars based in Italy, South Korea and New Zealand. Antonio Giordani's co-authors include Maurizio Anzini, Andrea Cappelli, Mariangela Biava, Francesco Makovec, Gianfranco Caselli, Salvatore Vomero, Carla Ghelardini, Lidia Sautebin, Antonietta Rossi and Giovanna Poce and has published in prestigious journals such as Journal of Medicinal Chemistry, Biomacromolecules and European Journal of Medicinal Chemistry.

In The Last Decade

Antonio Giordani

37 papers receiving 880 citations

Peers

Countries citing papers authored by Antonio Giordani

Since Specialization

Citations

This map shows the geographic impact of Antonio Giordani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Giordani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Giordani more than expected).

Fields of papers citing papers by Antonio Giordani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Giordani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Giordani. The network helps show where Antonio Giordani may publish in the future.

Co-authorship network of co-authors of Antonio Giordani

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Giordani. A scholar is included among the top collaborators of Antonio Giordani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Giordani. Antonio Giordani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis	European Journal of Medicinal Chemistry	Sara Consalvi, Giovanna Poce et al.	4
2	In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis	International Immunopharmacology	Sara Cheleschi, V. Calamia et al.	12
3	Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents	European Journal of Medicinal Chemistry	Alessandra Mancini, Angela Di Capua et al.	14
4	Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity	European Journal of Medicinal Chemistry	Angela Di Capua, Claudia Sticozzi et al.	31
5	The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)	Current Medicinal Chemistry	Natalia Rosso, V. Marin et al.	9
6	Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β	International Immunopharmacology	Sara Cheleschi, Nicola Antonio Pascarelli et al.	28
7	Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes	European Journal of Pharmaceutical Sciences	Claudia Sticozzi, Giuseppe Belmonte et al.	20
8	The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction	Pharmacological Research	Alma Martelli, Lara Testai et al.	22
9	Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors	Bioorganic & Medicinal Chemistry	Mariangela Biava, Claudio Battilocchio et al.	21
10	Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds	European Journal of Medicinal Chemistry	Andrea Cappelli, Salvatore Valenti et al.	28
11	Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme	European Journal of Medicinal Chemistry	Mariangela Biava, Claudio Battilocchio et al.	15
12	Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents	Current Medicinal Chemistry	Mariangela Biava, Giovanna Poce et al.	10
13	Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain	Journal of Pain Research	Marco Lanza, Ornella Letari et al.	43
14	Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4‐c]quinolin‐1‐one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors	ChemMedChem	Andrea Cappelli, Salvatore Valenti et al.	26
15	Progress Towards the Identification of New Aggrecanase Inhibitors	Current Medicinal Chemistry	Francesca De Rienzo, Puneet Saxena et al.	19
16	4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase	Bioorganic & Medicinal Chemistry Letters	Antonio Giordani, Paolo Pevarello et al.	22
17	Benzoylalanine Analogues as Inhibitors of Rat Brain Kynureninase and Kynurenine 3-Hydroxylase	Advances in experimental medicine and biology	Antonio Giordani, Michela Cini et al.	3
18	Enantiospecific Synthesis and in vitro Activity of Selective Inhibitors of Rat Brain Kynureninase and Kynurenine-3-Hydroxylase	Advances in experimental medicine and biology	Antonio Giordani, Michela Cini et al.	14
19	Agents Combining Thromboxane Receptor Antagonism with Thromboxane Synthase Inhibition: [[[2-(1H-Imidazol-1-yl)ethylidene]amino]oxy]alkanoic Acids	Journal of Medicinal Chemistry	Paolo Cozzi, Antonio Giordani et al.	23
20	(2S)-1-(Arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective .kappa. opioid analgesics	Journal of Medicinal Chemistry	Vittorio Vecchietti, Antonio Giordani et al.	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact